We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.55%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.06T
AUM Growth
-$16.9B
Cap. Flow
-$16.2B
Cap. Flow %
-1.53%
Top 10 Hldgs %
26.1%
Holding
3,048
New
131
Increased
1,029
Reduced
1,524
Closed
112

Top Buys

Rank Stock Value
1
XYZ
Block Inc
XYZ
+$2.39B
2
CVNA icon
Carvana
CVNA
+$1.82B
3
MSFT icon
Microsoft
MSFT
+$1.5B
4
DIS icon
Walt Disney
DIS
+$1.25B
5
SPOT icon
Spotify
SPOT
+$1.05B

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$2.65B
2
INTU icon
Intuit
INTU
+$2.08B
3
MTCH icon
Match Group
MTCH
+$1.87B
4
CRM icon
Salesforce
CRM
+$1.76B
5
META icon
Meta Platforms (Facebook)
META
+$1.61B

Sector Composition

Rank Sector Weight
1 Technology 25.08%
2 Healthcare 16.24%
3 Consumer Discretionary 15.33%
4 Communication Services 13.82%
5 Financials 12.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGLE
2701
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$206K ﹤0.01%
+4,089
New +$185K
UHT
2702
Universal Health Realty Income Trust
UHT
$573M
$205K ﹤0.01%
3,707
-43,608
-92% -$2.57M
MTTR
2703
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$205K ﹤0.01%
+10,850
New +$176K
BNFT
2704
DELISTED
Benefitfocus, Inc.
BNFT
$205K ﹤0.01%
18,439
+127
+0.7% +$1.54K
XOMA
2705
DELISTED
Xoma
XOMA
$204K ﹤0.01%
8,224
-3,096
-27% -$91.2K
AUY
2706
DELISTED
Yamana Gold, Inc.
AUY
$204K ﹤0.01%
51,629
LDL
2707
DELISTED
Lydall, Inc.
LDL
$204K ﹤0.01%
3,280
-3,731
-53% -$230K
PLCE icon
2708
Children's Place
PLCE
$53.4M
$203K ﹤0.01%
2,692
+30
+1% +$2.66K
LOGC
2709
DELISTED
ContextLogic
LOGC
$203K ﹤0.01%
+1,237
New +$308K
SUP
2710
DELISTED
Superior Industries International
SUP
$202K ﹤0.01%
28,600
-5,400
-16% -$42.1K
OYST
2711
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$202K ﹤0.01%
17,028
-962
-5% -$14K
ATHX
2712
DELISTED
Athersys, Inc. Common Stock
ATHX
$202K ﹤0.01%
6,060
ZIXI
2713
DELISTED
Zix Corporation
ZIXI
$202K ﹤0.01%
28,563
+324
+1% +$2.34K
NKLA
2714
DELISTED
Nikola Corporation Common Stock
NKLA
$201K ﹤0.01%
629
+64
+11% +$22.4K
MSP
2715
DELISTED
Datto Holding Corp.
MSP
$201K ﹤0.01%
+8,428
New +$218K
NPKI
2716
NPK International
NPKI
$1.18B
$199K ﹤0.01%
60,220
+293
+0.5% +$828
EUCR
2717
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$199K ﹤0.01%
20,300
WWR icon
2718
Westwater Resources
WWR
$75.2M
$198K ﹤0.01%
55,200
+29,100
+111% +$114K
ECVT icon
2719
Ecovyst
ECVT
$1.1B
$197K ﹤0.01%
16,905
-231
-1% -$3.15K
IMVT icon
2720
Immunovant
IMVT
$8.64B
$197K ﹤0.01%
22,680
+5,077
+29% +$45.8K
LPCN icon
2721
Lipocine
LPCN
$17M
$196K ﹤0.01%
10,580
+5,329
+101% +$118K
AWH
2722
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$196K ﹤0.01%
4,011
+2,213
+123% +$137K
EPIX
2723
DELISTED
ESSA Pharma
EPIX
$194K ﹤0.01%
24,303
OPTT icon
2724
Ocean Power Technologies
OPTT
$55.4M
$194K ﹤0.01%
83,600
+31,000
+59% +$64.9K
RFP
2725
DELISTED
Resolute Forest Products Inc.
RFP
$194K ﹤0.01%
16,300

Similar funds

T. Rowe Price Associates's Q3 2021 Portfolio in Review

As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
  • T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
  • T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
  • T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
  • T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
  • T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.

Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.